Abstract
Dexmedetomidine is a selective alpha-2-adrenoceptor agonist used as an adjuvant for regional anaesthesia. We studied its efficacy as an adjuvant to lidocaine in infraorbital nerve block in 90 patients divided equally into three groups. The first group (control) was given 2% lidocaine 2ml only, the second, 2% lidocaine 2ml with dexmedetomidine 14μg peripherally (peripheral group), and the third, 2% lidocaine 2ml peripherally with dexmedetomidine 14μg systemically (systemic group). Onset of anaesthesia, duration of action, blood pressure, oxygen saturation, and heart rate were evaluated. The mean (SD) onset of action was faster in the peripheral group (185 (39.02) seconds) than in the others (control: 261.67 (67.02); systemic: 217.37 (34.86) seconds). The duration of action was longer in the peripheral group (124.87 (19.75) minutes) than in the others (control: 70.43 (13.62); systemic: 88.83 (20.63) minutes). Differences in blood pressure, oxygen saturation, and heart rate measured at different intervals were not significant. The addition of 7mg/L dexmedetomidine to lidocaine perineurally speeds up the onset of action and prolongs the duration of anaesthesia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
